A combination of vinorelbine and carboplatin as first line treatment for patients with metastatic breast cancer - A phase II study.

被引：0
|
作者：
Protheroe, AS
Rodwell, S
Aram, H
Dodwell, D
Crawford, M
Bradley, C
Perren, TJ
Hill, S
Joffe, JK
机构：
[1] Huddersfield Royal Infirm, Huddersfield, W Yorkshire, England
[2] St James Univ Hosp, Imperial Canc Res Fund, Canc Med Res Unit, Leeds LS9 7TF, W Yorkshire, England
来源：
BRITISH JOURNAL OF CANCER | 2001年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [1] First-line treatment of metastatic breast cancer with mitoxantrone, vinorelbine, and carboplatin
    Kakolyris, S
    Kourousis, C
    Koukourakis, M
    Androulakis, N
    Vamvakas, L
    Agelaki, S
    Hatzidaki, D
    Samonis, G
    Tsiftsis, D
    Georgoulias, V
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (06): : 568 - 572
  • [2] Phase II study of carboplatin, vinorelbine and capecitabine in patients with metastatic breast cancer.
    Rabinowitz, MJ
    Mangalik, A
    Lee, FC
    Cynthia, C
    Claire, V
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S203 - S203
  • [3] VINORELBINE AND DOCETAXEL COMBINATION AS FIRST LINE TREATMENT IN PATIENTS WITH METASTATIC BREAST CANCER - RESULTS OF A MULTICENTRIC PHASE II TRIAL IN IRAN
    Ameri, A.
    Shahrad, B.
    Madani, H.
    Fazlalizadeh, A.
    Mousavizadeh, A.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 119 - 119
  • [4] Multicenter Phase II Study of Pegylated Liposomal Doxorubicin in Combination with Vinorelbine as First-Line Treatment in Elderly Patients with Metastatic Breast Cancer
    Mlineritsch, Brigitte
    Schabel-Moser, Renate
    Andel, Johannes
    Fridrik, Michael
    Moik, Martin
    Mayer, Peter
    Russ, Gudrun
    Rass, Christof
    Greil, Richard
    [J]. ONKOLOGIE, 2009, 32 (1-2): : 18 - 24
  • [5] Vinorelbine and infusional 5-fluorouracil as first line chemotherapy in elderly patients with metastatic breast cancer: a phase II study.
    Rozzi, A
    Salerno, M
    Ciorra, AA
    Traficante, D
    Magnolfi, E
    De Pettis, L
    Gemma, D
    Marchei, P
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S91 - S91
  • [6] Phase II study of vinorelbine and capecitabine as first-line treatment for metastatic breast cancer.
    El-Sadda, Wael
    Halim, Inas Ibraheim Abdel
    Aziz, Mohamed Abdel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Phase I/II study of biweekly vinorelbine and oxaliplatin as first-line treatment in patients with metastatic breast cancer
    Guerrero, Antonio
    Servitja, Sonia
    Rodriguez-Lescure, Alvaro
    Calvo, Lourdes
    del Barco, Sonia
    Teresa Quintanar, Maria
    Ignacio Juarez, Jose
    Gayo, Javier
    Llombart, Antonio
    Tusquets, Ignasi
    [J]. ANTI-CANCER DRUGS, 2011, 22 (03) : 283 - 289
  • [8] Phase Ib study of sorafenib and vinorelbine as first-line treatment in patients with metastatic breast cancer
    Ferrario, C.
    Charamis, H.
    Oyewole-Eletu, S.
    Mihalcioiu, C. L.
    Langleben, A.
    Miller, W. H.
    Aloyz, R.
    Panasci, L. C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] A phase II trial of capecitabine and vinorelbine as first-line treatment in patients with metastatic breast cancer (BC)
    Palumbo, Raffaella
    Bernardo, Antonio
    Strada, Maria Rosa
    Poggi, Guido
    Delmonte, Angelo
    Teragni, Cristina
    Frascaroli, Mara
    Bernardo, Giovanni
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 75 - 75
  • [10] Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study
    Donadio, M
    Ardine, M
    Berruti, A
    Ritorto, G
    Fea, E
    Mistrangelo, M
    Coccorullo, Z
    Bergnolo, P
    Comandone, A
    Bertetto, O
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 52 (02) : 147 - 152
12345